SPECTRAL CONTRAST ENHANCEMENT IN A COCHLEAR IMPLANT SPEECH PROCESSOR

Patent №

US 8,170,679

Granted

2012-05-01

Filed 2010

Owner

ADVANCED BIONICS CORPORATION

+1 more

Lab

AI components

1

speech

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

12765649

Psychophysical tests are administered to cochlear implant (CI) users to determine a spectral modulation transfer function (SMTF), smallest detectable spectral contrast as a function of spectral modulation frequency, for each individual CI user. The determined SMTF for individual CI user is compared against a SMTF of a normal hearing person to determine the specific enhancements needed. A profile of spectral enhancement achievable with variation of filter parameters, sigma and maximum that best fits the needed enhancements for the individual CI user is selected. Based on the corresponding sigma and maximum selected, a sound processing strategy is adjusted to provide customized spectral contrast enhancement for the individual CI user. The sound processing strategy implemented includes an outer hair cell model.

SpeechH04R 25/70A61N 1/36039A61N 1/36038

AI classification

Speech0.98
Planning0.01
Vision0.00
Evolutionary computation0.00
Machine learning0.00
AI hardware0.00
Natural language0.00
Knowledge representation0.00

Ownership

ADVANCED BIONICS CORPORATION

assignment · 242750403

BOSTON SCIENTIFIC NEUROMODULATION CORPORATION

namechg · 242840809

Assignors

SAOJI, ANIKET, LITVAK, LEONID M., FRIDMAN, GENE Y.

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC